Associate Member
Department of Epidemiology
Division of Cancer Prevention and Population Sciences
Roswell Park Cancer Institute
Elm and Carlton Streets
Buffalo New York USA 14263
Tel: 716-845-8004
Fax: 716-845-1126
E-mail: kirsten.moysich@roswellpark.org

Associate Professor of Oncology
Roswell Park Cancer Institute

Associate Professor Department of Cancer Pathology and Prevention
Associate Professor Department of Social and Preventive Medicine
State University of New York at Buffalo

Dr. Kirsten B. Moysich joined the staff of Roswell Park Cancer Institute in 1998 and was appointed Associate Member in the Department of Epidemiology, Division of Cancer Prevention and Population Sciences in 2003. She also serves as Associate Professor of Oncology, Associate Professor, Department of Cancer Pathology and Prevention and Associate Professor, Department of Social and Preventive Medicine at the State University of New York at Buffalo. Dr. Moysich earned her doctoral degree in Epidemiology and Community Health (1996) and completed a postdoctoral fellowship in Social and Preventative Medicine at UB in 1998.

Her research interests focus on the role of regulatory T cells (or Treg cells) in the etiology and prognosis of human cancers. Treg cells are a unique subset of T cell with immunosuppressive properties, which appear to be lower in patients with various immune conditions and higher among cancer patients. However, many of the previous studies on the role of Treg cells and cancer were relatively small and had important methodological limitations. Dr. Moysich is applying rigorous epidemiological methods to gain a more definitive understanding on the association between Treg cells and cancer. She is also interested in the relationship between genes that influence Treg cell activity and cancer etiology and prognosis. Dr. Moysich currently holds funding to study Treg cells in the etiology and prognosis of breast cancer, ovarian cancer and multiple myeloma. In addition, Dr. Moysich’s research program includes pharmacogenetic studies of acute leukemia and ovarian cancer. She is also interested in the effect of common exposures, such as aspirin use or coffee consumption, in the development of solid and hematological malignancies.

Dr. Moysich is very involved with the cancer advocacy community and has given numerous local and national presentations on a variety of cancer related topics. She serves on the faculty of the National Breast Cancer Coalition’s Project Lead program and the Member of the Healthcare Advisory Council of Gilda’s Club Western New York. Dr. Moysich is a member of the American Association for Cancer Research (Molecular Epidemiology Group Outreach and Membership Committees), American College of Epidemiology, International Society for Environmental Epidemiology, Molecular Epidemiology Group and Women in Cancer Research.

Dr. Moysich has authored or co-authored more than 70 peer-reviewed journal publications. She is an ad-hoc reviewer for more than 20 journals, including, the American Journal of Epidemiology, Cancer, Cancer Epidemiology, Biomarkers & Prevention, Cancer Research, Clinical Cancer Research, Epidemiology, International Journal of Cancer, Journal of the National Cancer Institute, and Lancet. She has served on numerous study sections including those organized by the National Cancer Institute, Department of Defense Breast and Ovarian Cancer Research Programs, Susan G. Komen Foundation, and the California Breast Cancer Research Program.  

Key Publications

• Moysich KB, Mettlin C, Piver MS, Natarajan N, Menezes RJ, Swede H. Regular Use of Analgesic Drugs and Ovarian Cancer Risk. Cancer Epidemiology, Biomarkers and Prevention 2001; 10:903-906.
• Moysich KB, Menezes RJ, Michalek AM. Chernobyl-Related Ionizing Radiation Exposure and Cancer Risk – A Review of the Epidemiological Literature. Lancet Oncology 2002;3:269-279.
• Davis S, Day RW, Kopecky KJ, Mahoney MC, McCarthy PL, Michalek AM, Moysich KB, Onstad LE, Stepanenko VF, Voillequé PG. The Chernobyl Power Station Accident: Results From an International Collaborative Population-Based Case-Control Study. International Journal of Epidemiology 2006; 35:386-96.
• Baker JA, Beehler GP, Sawant AC, Jayaprakash V, McCann SE, and Moysich KB*. Consumption of coffee, but not black tea, is associated with decreased risk of premenopausal breast cancer. Journal of Nutrition 2006;136:166-71.
• Moysich KB, Baker JA, Rodabaugh KJ, Villella JA. Regular analgesic use and risk of endometrial cancer. Cancer Epidemiology, Biomarkers, and Prevention 2005;14:2923-8.
• Jayaprakash V, Menezes RJ, Javle MM, McCann SE, Baker JA, Reid ME, Natarajan N, Moysich KB. Regular aspirin use and esophageal cancer risk. Regular aspirin use and risk of cancer of the esophagus. International Journal of Cancer. 2006;119:202-7.
• Baker JA, Boakye K, McCann SE, Beehler GP, Rodabaugh KJ, Villella JA, Moysich KB. Consumption of black tea or coffee and risk of ovarian cancer. International Journal of Gynecological International Journal of Gynecological Cancer 2007;17:50-54.
• Moysich KB, Bonner MR, Beehler GP, Marshall JR, Menezes RJ, Baker JA, Weiss JR, Chanan-Khan A. Regular Analgesic Use and Risk of Multiple Myeloma. Leukemia Research 2007; 31:547-51.
• Moysich KB, Baker JA, Menezes RJ, Jayaprakash V, Rodabaugh KJ, Odunsi K, Beehler GP, Zirpoli G, McCann ME, Villella JA. Usual Adult Body Mass Index is Not Predictive of Ovarian Cancer Survival. Cancer Epidemiology Biomarkers and Prevention 2007;16 626-628.
• Baker JA, Boakye K, McCann SE, Beehler GP, Rodabaugh KJ, Villella JA, Moysich KB. Consumption of black tea or coffee and risk of ovarian cancer. International Journal of Gynecological International Journal of Gynecological Cancer 2007;17:50-54.